Torrent Pharmaceuticals Ltd - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates23-05-2019
23-05-2019
Torrent Pharmaceuticals Ltd - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of Duplicate Share Certificate23-05-2019
India operations to offset challenges in US market for Torrent Pharma
Further correction in stock could present a buying opportunity21-05-2019
TORRENT PHARMACEUTICALS LTD. - 500420 - Submission / Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), 2015, ('Listing Regulations')
We would like to inform that the Board has at its meeting held today approved, inter-alia, the re-appointment of Shri Samir Mehta as Executive Chairman of the Company for the period from 30-Jul-19 till 31-Mar-20 subject to approval of the shareholders. Further, we would like to inform that Shri Mehta is not debarred from holding the office of director by virtue of any SEBI order or any other such authority.20-05-2019
TORRENT PHARMACEUTICALS LTD. - 500420 - Re-Submission / Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), 2015, ('Listing Regulations')
In continuation to our letter dated 20-May-19, we are hereby submitting the copy of the standalone and consolidated financial results for the quarter and year ended on 31st March, 2019 again since the page no. 2 of the respective results seems to have not be transmitted.20-05-2019
Torrent Pharmaceuticals Ltd - 500420 - Intimation Of Record Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Friday, 14th June, 2019 as the Record Date for taking record of the Members of the Company entitled for final dividend for the year 2018-19, if declared by the Company.20-05-2019
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 201920-05-2019
Torrent Pharmaceuticals Ltd - 500420 - Board recommends Final Dividend
Torrent Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 20, 2019, inter alia, has recommended to the members a final dividend of Rs. 4/- (80%) per equity share of Rs. 5 each. The final dividend amount, if declared by the Shareholders, are proposed to be paid / dispatched on or around July 26, 2019.20-05-2019
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Date of payment of Dividend
We would like to inform that the Board has at its meeting held today approved, inter-alia, recommended to the members a final dividend of Rs. 4/- (80%) per equity share of Rs. 5 each. The final dividend amount, if declared by the Shareholders, are proposed to be paid / dispatched on or around 26th July, 2019. As per Regulation 42 of the Listing Regulations, the Company has fixed Friday, 14th June, 2019 as the Record Date for the said purpose. The dividend, if declared, shall be payable to those shareholders whose name appears on the Register of Members or on records of National Securities Depositories Limited or Central Depositories Services (India) Limited as beneficial owners as on said Record Date.20-05-2019
Torrent Pharmaceuticals Ltd - 500420 - Submission / Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), 2015, ('Listing Regulations')
We would like to inform that the Board has at its meeting held today approved, inter-alia, the following: (a) Audited Financial Results (both standalone and consolidated) of the Company along with audit reports for the quarter and year ended on 31st March, 2019. The said financial results are enclosed herewith. We declare that the aforesaid Audit Reports are with unmodified opinion. In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of Audited Consolidated Financial Results for the quarter and year ended on 31st March, 2019. Both Audited Standalone and Consolidated Financial Results will be available at Company's website www.torrentpharma.com. A Press Release on Financial Results which is being submitted to the media is also enclosed herewith.20-05-2019